A Comparison of a New Acoustic Feedback Canceller in Hearing Aids With the Current System
Hearing Loss
About this trial
This is an interventional treatment trial for Hearing Loss
Eligibility Criteria
Inclusion Criteria:
- All classifications of hearing loss (sensorineural, conductive, mixed)
- Conductive and mixed hearing loss must be approved for amplification by a physician
- All shapes of hearing loss (flat, sloping, reverse slope, notch)
- Severity ranging from mild to profound
- German speaking
- Ability and willingness to sign the consent form
Exclusion Criteria:
- Contraindications for amplification
- Active ear disease
- New hearing aid users
- Inability to follow the procedures
- Reduced mobility that makes then unable to attend study Appointments
- Uncooperative so that it's not possible to get a valid audiogram
- A strongly reduced dexterity
- Central hearing disorder
- Sponsor employees
- Family members of Sponsor employees
Sites / Locations
- Bernafon
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Moderate Hearing loss current Mermaid first, then new
Moderate Hearing loss new Mermaid first, then current
Severe hearing loss current Power first, then new
Severe hearing loss new Power first, then current
Participants were randomized to wear the current Mermaid hearing aid that uses the current feedback cancellation first for 10 days. Then they wore the new Mermaid Hearing aid for another 10 days.
Participants were randomized to wear the new Mermaid hearing aid that uses the new feedback cancellation first for 10 days. Then they wore the current Mermaid Hearing aid for another 10 days.
Participants were randomized to wear the current power hearing aid that uses the current feedback cancellation first for 10 days. Then they wore the new power Hearing aid for another 10 days.
Participants were randomized to wear the new power hearing aid that uses the new feedback cancellation first for 10 days. Then they wore the current power Hearing aid for another 10 days.